P3 Health Partners Inc.
PIII
$5.02
-$0.01-0.20%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.44B | 1.46B | 1.49B | 1.50B | 1.48B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.44B | 1.46B | 1.49B | 1.50B | 1.48B |
| Cost of Revenue | 1.50B | 1.54B | 1.55B | 1.56B | 1.52B |
| Gross Profit | -58.45M | -73.71M | -64.17M | -58.92M | -40.20M |
| SG&A Expenses | 102.84M | 107.81M | 111.38M | 113.93M | 107.25M |
| Depreciation & Amortization | 84.32M | 84.96M | 85.57M | 86.06M | 86.54M |
| Other Operating Expenses | 1.26M | 43.17M | 45.74M | 53.70M | 12.43M |
| Total Operating Expenses | 1.69B | 1.77B | 1.79B | 1.81B | 1.72B |
| Operating Income | -246.88M | -309.65M | -306.86M | -312.60M | -246.42M |
| Income Before Tax | -278.50M | -315.51M | -301.63M | -305.99M | -249.14M |
| Income Tax Expenses | 8.02M | 4.40M | 3.39M | 4.39M | 1.20M |
| Earnings from Continuing Operations | -286.52 | -319.91 | -305.02 | -310.38 | -250.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 155.47M | 173.94M | 167.39M | 174.53M | 147.64M |
| Net Income | -131.05M | -145.97M | -137.63M | -135.85M | -102.69M |
| EBIT | -246.88M | -309.65M | -306.86M | -312.60M | -246.42M |
| EBITDA | -162.56M | -224.69M | -221.29M | -226.54M | -159.88M |
| EPS Basic | -47.32 | -52.02 | -50.18 | -51.77 | -37.67 |
| Normalized Basic EPS | -7.96 | -9.42 | -8.80 | -7.31 | -2.20 |
| EPS Diluted | -51.23 | -57.26 | -58.39 | -59.97 | -60.90 |
| Normalized Diluted EPS | -7.96 | -9.36 | -8.74 | -7.25 | -2.14 |
| Average Basic Shares Outstanding | 12.13M | 12.10M | 11.56M | 10.68M | 10.65M |
| Average Diluted Shares Outstanding | 12.13M | 12.15M | 11.71M | 10.83M | 10.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |